West Pharmaceutical Services | WST - Current Assets


West Pharmaceutical Services reported $1.82B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Align Technology USD 2.73B 63.03M Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dentsply International USD 1.98B 50M Sep/2026
Haemonetics USD 855.53M 44.7M Sep/2026
ICU Medical USD 1.22B 8.96M Sep/2026
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Merit Medical Systems USD 1.2B 86.58M Sep/2026
Neogen USD 582.5M 22.1M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.45B 69.4M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Rockwell Medical USD 31.61M 1.42M Jun/2025
Solventum Corp USD 3.69B 49M Sep/2026
STAAR Surgical USD 353.43M 11.08M Sep/2026
Terumo JPY 877.74B 28.86B Sep/2026
Utah Medical Products USD 100.38M 2.64M Mar/2026
West Pharmaceutical Services USD 1.82B 9M Sep/2026